Search

Your search keyword '"Itch-relief cream"' showing total 3 results
Start Over Descriptor "Itch-relief cream"
3 results on '"Itch-relief cream"'

1. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis.

Author

Saraceno, Rosita, Chiricozzi, Andrea, Nisticò, Steven Paul, Tiberti, Sergio, and Chimenti, Sergio

Subjects
*PRURIGO, *OCCLUSIVE surgical dressings, *OINTMENTS, *ITCHING, *NODULAR disease, *PREVENTION, *THERAPEUTICS
Abstract

Introduction: Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus. Objective: To assess the clinical efficacy and safety of betamethasone valerate 0.1% tape and a moisturizing itch-relief cream in prurigo nodularis. Methods: Twelve patients were enrolled in this pilot comparison of betamethasone valerate 0.1% tape versus a moisturizing itch-relief cream containing feverfew. The study period was 4 weeks. Clinical evaluation was performed weekly. Results: Eleven subjects completed the 4 weeks of therapy. The mean visual analogue scale (VAS) for pruritus at baseline was 8.75 for both sides of the body. The side treated with betamethasone valerate 0.1% tape showed a higher clinical response (VAS score at week 4: 3.9; p < 0.005) compared with the side treated with moisturizing itch-relief cream (VAS score at week 4: 5.6; p < 0.005). Conclusion: Both treatments were effective. However, the occlusive dressing enhanced the efficacy of the treatment, preventing scratching. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

2. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis

Author

Steven Paul Nistico, Rosita Saraceno, Andrea Chiricozzi, Sergio Tiberti, and Sergio Chimenti

Subjects
Adult, Male, medicine.medical_specialty, medicine.drug_class, Visual analogue scale, Pilot Projects, Dermatology, Occlusive Dressings, Prurigo nodulare, Tanacetum parthenium, chemistry.chemical_compound, Medicine, Humans, Surgical Tape, skin and connective tissue diseases, Vas score, Aged, Betamethasone Valerate, Betamethasone valerate 0.1%, Emollients, Occlusion, business.industry, Itch-relief cream, Antipruritics, Middle Aged, medicine.disease, Betamethasone valerate, Occlusive dressing, Tape, Treatment Outcome, chemistry, Corticosteroid, Betamethasone, Female, Prurigo, Settore MED/35 - MALATTIE CUTANEE E VENEREE, Surgical tape, business, Prurigo nodularis, medicine.drug, Phytotherapy
Abstract

Introduction: Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus. Objective: To assess the clinical efficacy and safety of betamethasone valerate 0.1% tape and a moisturizing itch-relief cream in prurigo nodularis. Methods: Twelve patients were enrolled in this pilot comparison of betamethasone valerate 0.1% tape versus a moisturizing itch-relief cream containing feverfew. The study period was 4 weeks. Clinical evaluation was performed weekly. Results: Eleven subjects completed the 4 weeks of therapy. The mean visual analogue scale (VAS) for pruritus at baseline was 8.75 for both sides of the body. The side treated with betamethasone valerate 0.1% tape showed a higher clinical response (VAS score at week 4: 3.9; p < 0.005) compared with the side treated with moisturizing itch-relief cream (VAS score at week 4: 5.6; p < 0.005). Conclusion: Both treatments were effective. However, the occlusive dressing enhanced the efficac...

Published
2010

3. An occlusive dressing containing betamethasone valerate 0.1% for the treatment of prurigo nodularis

Author

Saraceno, R., Chiricozzi, Andrea, Nistic, S. P., Tiberti, S., Chimenti, S., Chiricozzi A. (ORCID:0000-0002-6739-0387), Saraceno, R., Chiricozzi, Andrea, Nistic, S. P., Tiberti, S., Chimenti, S., and Chiricozzi A. (ORCID:0000-0002-6739-0387)

Abstract

Introduction: Prurigo nodularis is a distressing condition characterized by the presence of multiple nodules associated with intense pruritus. Objective: To assess the clinical efficacy and safety of betamethasone valerate 0.1% tape and a moisturizing itch-relief cream in prurigo nodularis. Methods: Twelve patients were enrolled in this pilot comparison of betamethasone valerate 0.1% tape versus a moisturizing itch-relief cream containing feverfew. The study period was 4 weeks. Clinical evaluation was performed weekly. Results: Eleven subjects completed the 4 weeks of therapy. The mean visual analogue scale (VAS) for pruritus at baseline was 8.75 for both sides of the body. The side treated with betamethasone valerate 0.1% tape showed a higher clinical response (VAS score at week 4: 3.9; p < 0.005) compared with the side treated with moisturizing itch-relief cream (VAS score at week 4: 5.6; p < 0.005). Conclusion: Both treatments were effective. However, the occlusive dressing enhanced the efficacy of the treatment, preventing scratching. © 2010 Informa Healthcare USA on behalf of Informa UK Ltd.

Published
2010

Catalog

Books, media, physical & digital resources
See catalog results